Literature DB >> 54236

Quantification of IgG subclasses in sera of normal adults and healthy children between 4 and 12 years of age.

M van der Giessen, E Rossouw, T A van Veen, E van Loghem, B J Zegers, P C Sander.   

Abstract

The concentration of the four subclasses of IgG was determined in sera of normal adults and healthy children between 4 and 12 years of age, using the radial immunodiffusion technique. A relation between the concentration of IgG subclasses and Gm type was studied in adults. No influence of Gm type on IgG1 concentration could be shown, except that the group of Gm(fb) individuals had a higher level than the others. The mean concentration of IgG2 was higher in sera positive for Gm(n) than in those lacking this genetic marker. High IgG3 concentrations corresponded to the presence of Gm(b). No clearcut evidence was obtained for a relation between IgG4 concentration and Gm factors, although in general Gm(n) positive individuals had higher and Gm (zag) positive individuals lower concentrations of this subclass in their serum. Quantification of IgG subclasses in sera from healthy children of different ages revealed that the amount of IgG2 rises slowly with age, having not yet reached the adult level at the age of 12 years. This also holds for IgG4, although in a lesser degree. No significant differences from the adult level were found for the concentrations of IgG1 and IgG3.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 54236      PMCID: PMC1538307     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Quantitative immunoglobulin levels (IgG, IgA and IgM) in children.

Authors:  C Collins-Williams; S J Tkachyk; B Toft; M Moscarello
Journal:  Int Arch Allergy Appl Immunol       Date:  1967

2.  The development of immunoglobulin levels in man.

Authors:  M Allansmith; B H McClellan; M Butterworth; J R Maloney
Journal:  J Pediatr       Date:  1968-02       Impact factor: 4.406

3.  Qualitative and quantitative studies on IgG2 globulins in individual human sera with an antiserum capable of differentiating between Gm(n+) and Gm(n-) proteins.

Authors:  M van der Giessen; W Freyee; E Rossouw; E van Loghem
Journal:  Clin Exp Immunol       Date:  1973-05       Impact factor: 4.330

4.  Quantitation of immunoglobulins in normal children.

Authors:  J A Uffelman; W E Engelhard; C R Jolliff
Journal:  Clin Chim Acta       Date:  1970-04       Impact factor: 3.786

5.  Immunoglobulin levels during childhood, with special regard to IgE.

Authors:  T Berg; S G Johansson
Journal:  Acta Paediatr Scand       Date:  1969-09

6.  Genetic marker of the gamma-A2 subgroup of gamma-A immunoglobulins.

Authors:  H G Kunkel; W K Smith; F G Joslin; J B Natvig; S D Litwin
Journal:  Nature       Date:  1969-09-20       Impact factor: 49.962

7.  Serum immunoglobulin levels in healthy children and adults.

Authors:  J W Stoop; B J Zegers; P C Sander; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

8.  RElation of the human antibody response to flagellin to GM genotype.

Authors:  J V Wells; H H Fudenberg; I R MacKay
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

9.  Genetic variants of G4 globulin. A unique relationship to other classes of G globulin.

Authors:  H G Kunkel; F G Joslin; G M Penn; J B Natvig
Journal:  J Exp Med       Date:  1970-09-01       Impact factor: 14.307

10.  Studies of the Vi (gamma-2c) subgroup of gamma-globulin. A relationship between concentration and genetic type among normal individuals.

Authors:  W J Yount; H G Kunkel; S D Litwin
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

View more
  34 in total

1.  Allotype-associated differences in concentrations of human IgG subclasses.

Authors:  H Sarvas; N Rautonen; O Mäkelä
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

2.  Asymmetric depression in the serum level of IgG subclasses in patients with nephrotic syndrome.

Authors:  F Shakib; J Hardwicke; D R Stanworth; R H White
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

3.  Factors influencing immunoglobulin levels.

Authors:  L S Salimonu
Journal:  Indian J Pediatr       Date:  1976-04       Impact factor: 1.967

4.  Serum IgG subclass concentrations in healthy subjects at different age: age normal percentile charts.

Authors:  A Plebani; A G Ugazio; M A Avanzini; P Massimi; L Zonta; V Monafo; G R Burgio
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

5.  Development of serum antibodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infections.

Authors:  B A Claesson; T Lagergård; B Trollfors
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

6.  Susceptibility to infections in children with selective IgA- and IgA-IgG subclass deficiency.

Authors:  A Morell; E Muehlheim; U Schaad; F Skvaril; E Rossi
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

7.  Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders.

Authors:  E Brouwer; J W Tervaert; G Horst; M G Huitema; M van der Giessen; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

8.  Serum IgG subclass antibodies to gliadin and other dietary antigens in children with coeliac disease.

Authors:  S Husby; N Foged; V A Oxelius; S E Svehag
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

9.  Atopy, immunological changes, and respiratory function in bronchiectasis.

Authors:  M B Murphy; D J Reen; M X Fitzgerald
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

10.  Serum IgG subclass deficiency in ataxia-telangiectasia.

Authors:  P Aucouturier; C Bremard-Oury; C Griscelli; M Berthier; J L Preud'homme
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.